Body mass index, diabetes, and C-reactive protein among U.S. Adults

Diabetes Care

Volumn 22, Issue 12, 1999, Pages 1971-1977

  Ford, Earl S ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; BODY MASS; DIABETES MELLITUS; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; REGRESSION ANALYSIS; UNITED STATES;

EID: 0033366583     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.12.1971     Document Type: Article

References (33)

1. Pepys MB: The acute phase response and C-reactive protein. In Oxford Textbook of Medicine: Weatherall DJ, Ledingham JGG, Warrell DA, Eds. New York, Oxford University Press, p. 1527-1533, 1996
2. Mendall MA, Patel P, Ballam L. Strachan D, Northfield TC: C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 312:1061-1065, 1996
3. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB: Production oi C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 349:462-466, 1997
4. Tracy RP, Psaty BM, Macy E, Bovill EG, Cushman M, Cornell ES, Kuller LH: Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Biol 17:2167-2176, 1997
5. Centers for Disease Control and Prevention: Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-94. Bethesda, MD, National Center for Health Statistics, 1994 (Vital Health Statistics 1)
6. Centers for Disease Control and Prevention: The Third National Health and Nutrition Examination Survey (NHANES III 1988-94) Reference Manuals and Reports. Bethesda, MD, National Center tor Health Statistics, 1996 (CD-ROM)
7. World Health Organization: Obesity: Preventing and Managing the Global Epidemic. Geneva, World Health Organization, 1998
8. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
9. Shah BV, Barnwell BG, Bieler GS: SUDAAN User's Manual, Version 7.5. Research Triangle Park, NC, Research Triangle Institute, 1997
10. Kushner I, Broder ML, Karp D: Control of the acute phase response: serum C-reactive protein kinetics after acute myocardial infarction. J Clin Invest 61:235-242, 1978
11. de Beer FC, Hind CR, Fox KM, Allan RM, Maseri A, Pepys MB: Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br Heart J 47:239-243, 1982
12. Heinrich J, Balleisen L, Schulte H, Assman G, van de Loo J: Fibnnogen and factor VII in the prediction of coronary risk: results from the PROCAM Study in healthy men. Arterioscler Thromb 14:54-59, 1994
13. Mori T, Sasaki J, Kawaguchi H, Handa K, Takada Y, Matsunaga A, Kono S, Arakawa K: Serum glycoproteins and severity of coronary atherosclerosis. Am Heart J 129:234-238, 1995
14. de Maat MPM, de Bart ACW, Hennis BC, Meijer P, Havelaar AC, Mulder PG, Kluft C: Interindividual and intraindividual variability in plasm fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris. Arterioscler Thromb Vasc Biol 16:1156-1162, 1996
15. Grau AJ, Buggle F, Becher H, Werle E, Hacke W: The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases. Thromb Res 82:245-255, 1996
16. Kuller LH, Tracy RP, Shaten J, Meilahn EN, for the MRFIT group: Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 144:537-547, 1996
17. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin, and the risk ot cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979, 1997
18. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, Mcilahn EN, Kuller LH: Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 17:1121-1127, 1997
19. Hotamisligil GS, Arner P, Caro JF Atkinson RL. Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95:2409-2415, 1995
20. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB: The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111-2119, 1995
21. Warren RS, Stames HF Jr, Gabrilove JL, Oettgen HF, Brennan MF: The acute metabolic effects of tumor necrosis factor administration in humans. Arch Surg 122:1396-1400, 1987
22. Hotamisligil GS, Shargill MS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87-91, 1993
23. Hirokawa J, Sakaue S, Furuya Y, Ishii J, Hasegawa A, Tagami S, Kawakami Y, Sakai M, Nishi S, Nishihira J: Tumor necrosis factor-alpha regulates the gene expression of macrophage migration inhibitory factor through tyrosine kinase-dependent pathway in 3T3-L1 adipocytes. J Biochem (Tokyo) 123:733-739, 1998
24. Baumann H, Gauldie J: Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med 7:147-159, 1990
25. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP: Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 82:1313-1316, 1997
26. O'Riordain MG, Ross JA, Fearon KC, Maingay J, Farouk M, Garden OJ, Carter DC: Insulin and counterregulatory hormones influence acute-phase protein production in human hepatocytes. Am J Physiol 269: E323-E330, 1995
27. Freedman DS, Joesoef MR, Barboriak JJ, Stallone DD, Byers T: Correlates of leukocyte counts in men. Ann Epidemiol 6:74-82, 1996
28. McMillan DE: Increased levels of acutephase serum proteins in diabetes. Metabolism 38:1042-1046, 1989
29. Juhan-Vague I, Thompson SG, Jespersen J: Involvement of the hemostatic system in the insulin resistance syndrome: a study of 1500 patients with angina pectoris: the ECAT Angina Pectoris Study Group. Arterioscler Thromb 13:1865-1873, 1993
30. Pickup JC, Mattock MB, Chusney GD, Burt D: NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40:1286-1292, 1997
31. Upchurch GR Jr, Keagy BA, Johnson G Jr.: An acute phase reaction in diabetic patients with foot ulcers. Cardiovasc Surg 5:32-36, 1997
32. van Eeden SF, Strachan AF, Hough SF: Circulating acute phase reactive proteins as indicators of infection in poorly controlled diabetes mellitus. Diabetes Res Clin Pract 5: 99-105, 1988
33. Ueta E, Osaki T, Yoneda K, Yamamoto T: Prevalence of diabetes mellitus in odontogenic infections and oral candidiasis: an analysis of neutrophil suppression. J Oral Pathol Med 22:168-174, 1993